| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |